Hunter C. Smith Salary and Compensation - RHYTHM PHARMACEUTICALS, INC. CEO Pay 2024

In fiscal year 2024, Hunter C. Smith, Chief Executive Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM), received total compensation of $5.1 million.

Hunter C. Smith's compensation breakdown includes: base salary of $499K, stock awards valued at $1.5 million, option awards of $2.7 million, non-equity incentive compensation of $352K, and other compensation of $14K.

Compared to fiscal year 2023, Hunter C. Smith's total compensation decreased 30% from $7.2 million to $5.1 million.

RHYTHM PHARMACEUTICALS, INC. (RYTM) Executive Pay 2024

RHYTHM PHARMACEUTICALS, INC.'s top 5 named executive officers received combined total compensation of $33.1 million in fiscal year 2024.

The named executive officers disclosed in RHYTHM PHARMACEUTICALS, INC.'s 2024 proxy statement are:Hunter C. Smith (Chief Executive Officer) with total compensation of $5.1 million, David P. Meeker (P. Meeker) with total compensation of $14.7 million, Yann Mazabraud (Head of North America) with total compensation of $5.6 million, Jennifer Chien (Lee) with total compensation of $4.3 million, and Joseph Shulman (Head of International) with total compensation of $3.4 million.